CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...

West, has voiced ‘serious concern’ following news that Nelipak Healthcare Packaging in Clara is seeking 40 voluntary ...

Trumpian policy is about elevating cultural policy above all else. He doesn’t have to win the cultural debates, but he will control the ideological agenda.

The EU will respond in a "firm and proportionate way" to a decision by US President Donald Trump to impose tariffs on the ...

The TRADE sits down with TD Securities’ Carl Hayes, head of European cash equities, and James Baugh, managing director and ...

Education leaders in Michigan shared their thoughts with News 10 on a batch of executive orders on education that could have a wide range of effects on Michigan’s education system.

Last week was another busy week for the White House, with several notable Executive Orders and more agency leadership changes ...

News of a significant price-target boost from an analyst tracking GDS Holdings ( GDS 7.20%) was the main catalyst behind the ...

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

The New Hampshire-based company is opening new gyms around the country, spurred by a CEO change that has helped propel its ...

China-based GDS Holdings (GDS) is surging 6% after investment bank TD Cowen raised its price target on the shares. The ...

Closely followed crypto analyst Benjamin Cowen says that a shift in monetary policy will most likely be what finally triggers an "altseason," or a period where altcoins vastly outperform Bitcoin (BTC) ...